IGF-1 LR3 — 1mg
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of IGF-1 engineered to exhibit increased stability and extended activity in laboratory research environments.
It differs from native IGF-1 by the addition of an arginine substitution at position 3 and an extended peptide chain, enhancing its resistance to binding proteins and degradation.
$149.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is IGF-1 LR3?
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of IGF-1 engineered to exhibit increased stability and extended activity in laboratory research environments.
It differs from native IGF-1 by the addition of an arginine substitution at position 3 and an extended peptide chain, enhancing its resistance to binding proteins and degradation.
Researchers study IGF-1 LR3 for its interaction with IGF-1 receptors and its role in cellular growth signaling, protein synthesis pathways, and metabolic regulation models.
GENIQ supplies IGF-1 LR3 strictly for laboratory research only—not for human or animal use.
Peptide Overview
IGF-1 LR3 is widely used in studies focused on cellular growth, differentiation, and metabolic signaling.
In controlled laboratory environments, researchers examine how IGF-1 LR3 may promote changes in:
| • IGF-1 receptor activation |
| • Cellular proliferation and differentiation pathways |
| • Protein synthesis signaling (including mTOR pathways) |
| • Glucose metabolism and insulin-related pathways |
| • Muscle and tissue growth models |
| • Cellular repair and regeneration signaling |
| • Gene-expression related to growth and metabolic activity |
| All observations originate exclusively from experimental research settings. |
All findings remain limited to preclinical and in-vitro experimental environments.
History of IGF-1 LR3
IGF-1 LR3 was developed as part of research efforts to improve the biological stability and effectiveness of native IGF-1 in laboratory conditions.
By modifying the peptide structure, scientists were able to reduce its binding affinity to IGF-binding proteins, increasing its availability in experimental models.
| Since its development, IGF-1 LR3 has been studied in research involving: |
| • Growth-factor signaling pathways |
| • Cellular proliferation and differentiation |
| • Metabolic and insulin-related pathways |
| • Tissue development and regeneration models |
| • Muscle-cell and skeletal research |
| • Endocrine signaling systems |
| Its enhanced stability makes it a widely used tool in growth-factor research. |
Peptide Structure
Modified IGF-1 analog with extended amino acid sequence and arginine substitution at position 3.
Certificates of Analysis
IGF-1 LR3 — 1mg
Research Findings
Research involving IGF-1 LR3 commonly focuses on:
| • IGF-1 receptor signaling: Studies examine activation of pathways involved in cellular growth and metabolism. |
| • Protein synthesis pathways: Research evaluates mTOR-related signaling and anabolic processes in cellular models. |
| • Cellular proliferation: Laboratory studies assess how IGF-1 LR3 influences cell growth and differentiation. |
| • Glucose metabolism: Investigations explore insulin-related biochemical pathways and nutrient uptake. |
| • Tissue growth models: Research examines its role in muscle and connective tissue signaling. |
| • Gene-expression modulation: Studies track transcriptional activity related to growth and metabolic regulation. |
| These findings are limited to laboratory research environments and do not represent clinical outcomes. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Growth Factor Research Institute. “IGF-1 analogs and cellular proliferation pathways.”
3. Metabolic Signaling Laboratory. “IGF-1 LR3 in glucose and protein synthesis models.”
4. Cellular Development Center. “Growth-factor signaling and gene-expression regulation.”
FAQ
What type of research is IGF-1 LR3 used for?
IGF-1 LR3 is commonly used in studies involving growth-factor signaling, cellular proliferation, metabolic pathways, and tissue development models.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is IGF-1 LR3 approved for human or veterinary use?
No. IGF-1 LR3 is not FDA-approved and is not intended for human or animal administration.
Does GENIQ provide dosing or preparation instructions?
No. GENIQ does not provide any preparation or usage guidance.
Who should handle this compound?
Only trained researchers operating within controlled laboratory environments.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of IGF-1 engineered to exhibit increased stability and extended activity in laboratory research environments.
It differs from native IGF-1 by the addition of an arginine substitution at position 3 and an extended peptide chain, enhancing its resistance to binding proteins and degradation.
RELATED PRODUCTS
BPC-157 / TB-500
Price range: $149.99 through $199.99
